Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase

被引:16
|
作者
Jiang, Y. [1 ,3 ]
Ng, T. B. [2 ]
Wang, C. R. [1 ]
Zhang, D. [1 ]
Cheng, Z. H. [1 ]
Liu, Z. K. [1 ]
Qiao, W. T. [3 ]
Geng, Y. Q. [3 ]
Li, N. [1 ]
Liu, F. [1 ,3 ]
机构
[1] Nankai Univ, Dept Microbiol, Coll Life Sci, Tianjin 300071, Peoples R China
[2] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China
[3] Nankai Univ, Ctr AIDS Res, Tianjin 300071, Peoples R China
关键词
HIV-1; RT; PR; IN; natural products; HUMAN-IMMUNODEFICIENCY-VIRUS; BIOLOGICAL-PROPERTIES; ANTIFUNGAL PROTEIN; FUNGAL METABOLITE; MEDICINAL-PLANTS; AGASTACHE-RUGOSA; BINDING LECTIN; MUSHROOM; ACID; TRITERPENOIDS;
D O I
10.2174/138955710793564133
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Acquired immunodeficiency syndrome (AIDS), caused by human immunodeficiency virus type 1 (HIV-1) infection, is still one of the most challenging diseases of the early 21st century. Reverse transcriptase (RT), protease (PR) and integrase (IN) are three key enzymes of HIV-1. Despite the shortcomings of chemical drugs such as toxicity, lack of curative and multiple effects, the search for more and better anti-HIV agents has been focused on natural products. Many natural products have been shown to possess promising activities that could assist in the prevention and amelioration of the disease. Most of these natural anti-HIV agents have other medicinal values as well, which afford them further prospective as novel lead compounds for the development of new drugs. These natural products can deal with both the virus and the various disorders that are caused by HIV. In this review, natural inhibitors of RT, PR and IN have been found to be classified and the relationship between structure and inhibitory activity is discussed.
引用
收藏
页码:1331 / 1344
页数:14
相关论文
共 50 条
  • [21] Biochemical interactions between HIV-1 integrase and reverse transcriptase
    Chakraborty, Amit
    Sun, Gui-Quan
    Mustavich, Laura
    Huang, Sheng-He
    Li, Bai-Lian
    FEBS LETTERS, 2013, 587 (05) : 425 - 429
  • [22] Novel HIV-1 reverse transcriptase inhibitors
    Jochmans, Dirk
    VIRUS RESEARCH, 2008, 134 (1-2) : 171 - 185
  • [23] Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study
    Marco Floridia
    Serena Dalzero
    Vania Giacomet
    Enrica Tamburrini
    Giulia Masuelli
    Valeria Savasi
    Arsenio Spinillo
    Beatrice Tassis
    Laura Franceschetti
    Anna Maria Degli Antoni
    Matilde Sansone
    Giovanni Guaraldi
    Antonella Vimercati
    Alessandra Meloni
    Marina Ravizza
    Infection, 2020, 48 : 249 - 258
  • [24] An overview on HIV-1 reverse transcriptase inhibitors
    Ravichandran, Shalini
    Veerasamy, Ravichandran
    Raman, Saraswathi
    Krishnan, Palamadai Neelakandam
    Agrawal, Ram Kishore
    DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2008, 3 (04) : 171 - 187
  • [25] Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study
    Floridia, Marco
    Dalzero, Serena
    Giacomet, Vania
    Tamburrini, Enrica
    Masuelli, Giulia
    Savasi, Valeria
    Spinillo, Arsenio
    Tassis, Beatrice
    Franceschetti, Laura
    Antoni, Anna Maria Degli
    Sansone, Matilde
    Guaraldi, Giovanni
    Vimercati, Antonella
    Meloni, Alessandra
    Ravizza, Marina
    INFECTION, 2020, 48 (02) : 249 - 258
  • [26] Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
    Mark J. Siedner
    Michelle A. Moorhouse
    Bryony Simmons
    Tulio de Oliveira
    Richard Lessells
    Jennifer Giandhari
    Stephen A. Kemp
    Benjamin Chimukangara
    Godspower Akpomiemie
    Celicia M. Serenata
    Willem D. F. Venter
    Andrew Hill
    Ravindra K. Gupta
    Nature Communications, 11
  • [27] Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
    Siedner, Mark J.
    Moorhouse, Michelle A.
    Simmons, Bryony
    de Oliveira, Tulio
    Lessells, Richard
    Giandhari, Jennifer
    Kemp, Stephen A.
    Chimukangara, Benjamin
    Akpomiemie, Godspower
    Serenata, Celicia M.
    Venter, Willem D. F.
    Hill, Andrew
    Gupta, Ravindra K.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [28] Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors
    Walter, H
    Schmidt, B
    Korn, K
    Vandamme, AM
    Harrer, T
    Überla, K
    JOURNAL OF CLINICAL VIROLOGY, 1999, 13 (1-2) : 71 - 80
  • [29] In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors
    Leitao, Andrei
    Andricopulo, Adriano D.
    Montanari, Carlos A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (07) : 1412 - 1422
  • [30] Inhibition of HIV-1 reverse transcriptase and its binding to HIV-1 integrase by modified oligonucleotides
    Korolev, S.
    Kondrashina, O.
    Lysenko, E.
    Gottikh, M.
    FEBS JOURNAL, 2013, 280 : 84 - 85